PYRROLE SUBSTITUTED 2-INDOLINONE, PHARMACEUTICAL COMPOSITION, METHOD OF MODULATING CATALYTIC ACTIVITY OF PROTEIN KINASE, METHOD OF PREVENTION AND TREATMENT OF DISORDERS RELATED TO PROTEIN KINASE,申请号EA20020000862-传众专利搜索

发明名称	PYRROLE SUBSTITUTED 2-INDOLINONE, PHARMACEUTICAL COMPOSITION, METHOD OF MODULATING CATALYTIC ACTIVITY OF PROTEIN KINASE, METHOD OF PREVENTION AND TREATMENT OF DISORDERS RELATED TO PROTEIN KINASE
摘要	The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
申请公布号	EA005996(B1)	申请公布日期	2005.08.25
申请号	EA20020000862	申请日期	2001.02.15
申请人	SUGEN, INC.;PHARMACIA &AMP;UPJOHN COMPANY	发明人	TANG, PENG, CHO;WEI, CHUNG, CHEN;LI, XIAOYUAN;LIANG, CONGXIN;MILLER, TODD;NEMATALLA, ASAAD, S.;VOJKOVSKY, TOMAS;HAWLEY, MICHAEL;SUN, LI;SHIRAZIAN, SHAHRZAD
分类号	C07D401/14;A61K31/404;A61K31/4178;A61K31/4439;A61K31/496;A61K31/506;A61K31/5377;A61K31/55;A61P3/10;A61P9/00;A61P17/06;A61P19/02;A61P29/00;A61P35/00;A61P37/00;A61P37/06;A61P43/00;C07D207/32;C07D207/33;C07D209/44;C07D401/12;C07D403/00;C07D403/06;C07D403/12;C07D403/14;C07D521/00;(IPC1-7):C07D403/06	主分类号	C07D401/14
代理机构		代理人
主权项
地址